Aldevron unveiled Alchemy™ cell-free DNA technology. The technology was designed to support development and preclinical programs, with a future cGMP offering expected to launch in 2025 to ...

In January, Aldevron unveiled its Alchemy cell-free DNA technology. Instead of using cells to produce DNA, Alchemy relies on enzymes to produce linear DNA that serves as a template for the ...

Lo’s discovery marked a new avenue of inquiry, and over the next 14 years, others confirmed his findings, methods were developed for the analysis of cell-free DNA (cfDNA) to identify fetal ...

In an eight-year study of more than 600 community-dwelling older adults, Johns Hopkins Medicine researchers say they have further linked levels of cell-free DNA (DNA fragments resulting from cell ...

Use of a standardized cell-free (cf)DNA-sequencing and cancer-screening protocol detected cancer in nearly half of pregnant or postpartum women who initially received unusual or nonreportable ...

Donor-derived cell-free DNA can aid detection, diagnosis, and monitoring of antibody-mediated rejection after kidney transplantation. Donor-derived cell-free DNA (dd-cfDNA) is a non-invasive ...

This so-called cell free DNA can be used to identify cancer at very early stages. In a breakthrough, scientists have now developed a method for detecting small amounts of cell-free RNA. When a cell is ...

"The combination of artificial intelligence, cell-free DNA fragmentomes and a pair of protein biomarkers in a simple blood test improved detection of ovarian cancer even in patients with early ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

We don't have these kinds of studies for the new blood testing, which is called cell-free DNA testing. For the new cell-free DNA testing, a small amount of a person's blood is tested for a large ...